IL277546A - Methods and compositions for treating coronaviral infections - Google Patents
Methods and compositions for treating coronaviral infectionsInfo
- Publication number
- IL277546A IL277546A IL277546A IL27754620A IL277546A IL 277546 A IL277546 A IL 277546A IL 277546 A IL277546 A IL 277546A IL 27754620 A IL27754620 A IL 27754620A IL 277546 A IL277546 A IL 277546A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- treating
- methods
- coronaviral
- infections
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL277546A IL277546A (en) | 2020-09-23 | 2020-09-23 | Methods and compositions for treating coronaviral infections |
IL301503A IL301503A (en) | 2020-09-23 | 2021-09-22 | Methods and compositions for treating coronaviral infections |
PCT/IL2021/051154 WO2022064494A2 (en) | 2020-09-23 | 2021-09-22 | Methods and compositions for treating coronaviral infections |
EP21802440.4A EP4217370A2 (en) | 2020-09-23 | 2021-09-22 | Methods and compositions for treating coronaviral infections |
US18/122,169 US20230263884A1 (en) | 2020-09-23 | 2023-03-16 | Methods and compositions for treating coronaviral infections |
US18/229,224 US20240009315A1 (en) | 2020-09-23 | 2023-08-02 | Methods of targeting agents to ace2 receptors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL277546A IL277546A (en) | 2020-09-23 | 2020-09-23 | Methods and compositions for treating coronaviral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
IL277546A true IL277546A (en) | 2022-04-01 |
Family
ID=81259506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL277546A IL277546A (en) | 2020-09-23 | 2020-09-23 | Methods and compositions for treating coronaviral infections |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL277546A (en) |
-
2020
- 2020-09-23 IL IL277546A patent/IL277546A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4097122A4 (en) | Compositions and methods for preventing and treating coronavirus infection-sars-cov-2 vaccines | |
EP4178575A4 (en) | Compositions and methods for inhibiting and treating coronavirus infections | |
EP4199950A4 (en) | Methods and compositions for treating coronavirus infections | |
EP4136254A4 (en) | Ace2-targeted compositions and methods for treating covid-19 | |
IL291727A (en) | Method and compositions for treating coronavirus infection | |
EP4096675A4 (en) | Compositions and methods for treating long covid | |
EP4114422A4 (en) | Compositions and methods for the treatment of intracellular bacterial infections | |
ZA202202370B (en) | Compositions and methods for treating viral infections | |
EP4138804A4 (en) | Methods and compositions for treating fungal infections | |
EP4132539A4 (en) | Compositions and methods for treating bacterial infections | |
EP3965799A4 (en) | Compositions and synergistic methods for treating infections | |
IL307872A (en) | Novel compositions and methods for treating coronavirus infections | |
EP4103192A4 (en) | Compositions and methods for treating coronavirus infections | |
EP4232160A4 (en) | Compositions and methods for preventing and treating coronaviruses | |
IL281447A (en) | Methods and compositions for treating viral infections | |
EP4138862A4 (en) | Compositions and methods for treating upper respiratory infections | |
IL277546A (en) | Methods and compositions for treating coronaviral infections | |
EP4009981C0 (en) | Method and compositions for treating coronavirus infection | |
EP4161646A4 (en) | Compositions and methods for treating virus infection | |
EP4149474A4 (en) | Methods for treating hair loss and compositions for same | |
EP4028426A4 (en) | Methods and compositions for treating staphylococcal infections | |
EP4188424A4 (en) | Compositions and methods for treating bacterial infections | |
GB202314878D0 (en) | Methods and compositions for treating clostridiodes difficile infections | |
IL309452A (en) | Compositions for treating viral infections and methods for same | |
EP4175627A4 (en) | Composition and method for treating infections |